韩国青光眼患者的治疗模式与用药依从性
该横断面观察性研究于2013年3月至11月在15家眼科诊所招募使用滴眼液≤2年的青光眼患者,通过自填问卷和病历回顾评估用药依从性。共纳入1050例患者,1046例可评估依从性,27.4%不依从,总依从率为90.6±17.8%。多因素分析显示男性及每日给药次数增加与不依从相关。
要点
- 27.4%的青光眼患者不依从,总依从率为90.6±17.8%。
- 男性不依从风险为女性的1.466倍(95%CI 1.106至1.943)。
- 每日给药次数每增加,不依从风险为1.328倍(95%CI 1.186至1.487)。
核心结论
- 约三分之一患者不依从,男性和每日给药次数增加与不依从相关。
- 作者认为应考虑更系统化的治疗策略以提高用药依从性,从而实现有效的青光眼管理。
研究设计与样本
- 横断面观察性研究,2013年3月至11月在15家眼科诊所招募使用滴眼液≤2年的患者。
- 通过自填问卷和病历回顾收集数据,共纳入1050例患者,1046例可评估依从性。
主要发现
- 27.4%的患者不依从。
- 总依从率为90.6±17.8%,依从组为96.8±5.5%,不依从组为56.6±24.7%。
- 最常用药物为单用前列腺素(PGA),其次为两类组合(β受体阻滞剂和碳酸酐酶抑制剂(CAI))及三类组合(PGA、β受体阻滞剂和CAI)。
- 多因素分析中,男性不依从风险为女性的1.466倍(95%CI 1.106至1.943),每日给药次数增加时不依从风险为1.328倍(95%CI 1.186至1.487)。
关键数值与推荐
- 用药依从性定义为患者自我报告在处方天数中≥80%的天数用药。
- 依从率计算为7天内实际给药次数除以总处方给药次数。
- 患者自我报告处方与医生处方的每日总剂量不同即视为不依从。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: This study aimed to investigate treatment patterns and medication adherence of glaucoma. It also identified key factors associated with non-adherence. METHODS: It was a cross-sectional, observational study. Patients who use eye-drops for ≤2 years were recruited at 15 eye clinics from March to November 2013. Data were collected through self-administered questionnaires and medical chart review. Medication adherence was evaluated using patients' self-report on pill count and defined as patients' administering drug for ≥80% of prescribed days. Medication adherence rate was calculated by dividing actual number of administration from total prescribed number of administration for 7 days. Patients whose self-reported prescription was different from total daily doses of physicians' prescription were considered as non-adherent. RESULTS: A total of 1050 patients included, and medication adherence rate was evaluated in 1046 patients whose verification of adherence was available. Of the total, 27.4% were non-adherent, and the medication adherence rates of the total, the adherent, and the non-adherent were 90.6±17.8%, 96.8±5.5% and 56.6±24.7%, respectively. The most commonly used medication was prostaglandin (PGA) alone and the second was combination of two-class (β-blocker and carbonic anhydrase inhibitor (CAI)) and three-class combination of PGA, β-blocker and CAI followed. In multivariate analysis, the risk of non-adherence was 1.466 times greater in males than in females (95% CI 1.106 to 1.943) and 1.328-fold greater as the daily number of administration was increased (95% CI 1.186 to 1.487). CONCLUSION: Approximately, one-third of the patients were non-adherent, and males and increased daily number of administration were associated with non-adherence. It highlights that more systematic treatment strategies should be considered for better medication adherence, leading to effective glaucoma management.
引用
- Kim CY, Park KH, Ahn J, et al. Treatment patterns and medication adherence of patients with glaucoma in South Korea. Br J Ophthalmol. 2017. PMID: 28270490. doi:10.1136/bjophthalmol-2016-308505
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。